Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.352
-0.006 (-1.65%)
Apr 29, 2026, 9:30 AM EDT - Market open
Theriva Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 16 | 7 | 5 | 7 | 7 | 36 | |
| Market Cap Growth | 404.10% | 45.79% | -33.57% | 6.57% | -80.86% | 369.38% | |
| Enterprise Value | 6 | 2 | -10 | -19 | -39 | -37 | |
| Last Close Price | 0.36 | 0.21 | 1.75 | 10.75 | 11.37 | 68.05 | |
| PB Ratio | 0.83 | 0.46 | 0.26 | 0.19 | 0.13 | 0.55 | |
| P/TBV Ratio | 1.07 | 0.46 | 0.26 | 0.23 | 0.15 | 0.55 | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.08 | 0.05 | 0.03 | 0.02 | |
| Net Debt / Equity Ratio | -0.68 | -0.68 | -0.53 | -0.53 | -0.73 | -1.01 | |
| Net Debt / EBITDA Ratio | 0.70 | 0.70 | 0.54 | 0.96 | 2.09 | 4.64 | |
| Net Debt / FCF Ratio | 0.62 | 0.62 | 0.59 | 1.10 | 2.09 | 5.10 | |
| Quick Ratio | 1.69 | 1.69 | 1.97 | 3.73 | 5.95 | 18.94 | |
| Current Ratio | 1.74 | 1.74 | 2.15 | 4.07 | 6.45 | 19.38 | |
| Return on Equity (ROE) | -137.82% | -137.82% | -87.31% | -38.93% | -32.82% | -40.38% | |
| Return on Assets (ROA) | -25.51% | -25.51% | -25.85% | -21.73% | -16.95% | -22.65% | |
| Return on Capital Employed (ROCE) | -53.20% | -53.20% | -67.40% | -45.60% | -29.80% | -21.40% | |
| Earnings Yield | -153.94% | -334.41% | -526.83% | -250.32% | -286.19% | -39.70% | |
| FCF Yield | -101.84% | -235.31% | -347.85% | -261.91% | -279.10% | -35.90% | |
| Buyback Yield / Dilution | -800.56% | -800.56% | -109.24% | -5.09% | -25.76% | -541.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.